Published in Neuron · View the paper (DOI)
A team of Rockefeller scientists has identified a specific type of nerve cell, called cholecystokinin (CCK)-expressing neurons, as the site where selective serotonin reuptake inhibitors (SSRIs) initiate their action. This discovery may pave the way for new antidepressants that act more quickly and produce fewer side effects.
Coverage from 2 institutions